mirtazapine has been researched along with Hypercholesterolemia in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Mellédo, JM | 1 |
| del Pilar Castillo Abadia, M | 1 |
| Newman, S | 1 |
| Bailey, D | 1 |
| Tsuyuki, R | 1 |
| Gyenes, G | 1 |
1 other study available for mirtazapine and Hypercholesterolemia
| Article | Year |
|---|---|
The effects of newer antidepressants on low-density lipoprotein cholesterol levels.
Topics: Antidepressive Agents, Tricyclic; Cholesterol, HDL; Cholesterol, LDL; Confounding Factors, Epidemiol | 2004 |